Keith Ligon
Director, Center for Patient Derived Models, Dana-Farber Cancer Institute · Mass General Brigham
Credentials: · · · · ·
History
- Present
Center for Patient Derived Models · Mass General Brigham
PresentDivision of Neuropathology · UCLA David Geffen School of Medicine/UCLA Medical Center
- Present
Center for Patient Derived Models · UCLA David Geffen School of Medicine/UCLA Medical Center
Research
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cell · 2019 · 2,158 citations
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Review · Genes & Development · 2007 · 1,832 citations
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Nature · 2019 · 1,159 citations
- PW
94 papers
64 papers
55 papers
54 papers · 2 as a fellow
- SR
48 papers
42 papers
36 papers
35 papers · 15 as a resident
Grants
- 2013–2029
National Cancer Institute · P50
Project lead · $4M · Brigham and Women's Hospital
- 2013–2028
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
National Cancer Institute · P01
Project lead · $1.4M · Brigham and Women's Hospital
- 2022–2027
Synthetic Lethalities to Cell Cycle Disruption in Glioma
National Cancer Institute · R01
PI · $3.3M · Dana-Farber Cancer Inst
- 2015–2026
Evolution of Gliomas During Treatment and Resistance
National Cancer Institute · R01
PI · $6.9M · Dana-Farber Cancer Inst